As mentioned before adropin regulates production of nitric oxide (NO) and it is well established that endothelial dysfunction in IBD patients is associated with the decreased production of NO, whereas studies showed that administration of anti TNF-α therapy in IBD leads to significant improvement of endothelial dysfunction35,36. The gene discussed is TNF; the disease is inflammatory bowel disease.